Xcout Intel
BreezeBio
BreezeBio is a biotechnology company headquartered in the South San Francisco area of California that develops precision genetic medicines.
Subscribe to see BreezeBio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
BreezeBio at a glance
BreezeBio is a biotechnology company headquartered in United States. Its most recent funding round, Series B, raised $60M in February 2026. Xcout tracks 2 named people at BreezeBio, including Kunwoo (Ryan) Lee (Chief Executive Officer).
BreezeBio leadership
- Kunwoo (Ryan) LeeChief Executive Officer
- Kevin SinIndependent Director
BreezeBio funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $60M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
BreezeBio competitors
A few of BreezeBio's closest competitors — see the full list of competitors and alternatives →
Encoded Therapeutics is a biotechnology company headquartered in South San Francisco, California, dedicated to developing next-generation genetic medicines designed to address the root causes of genetic diseases.
SonoThera, Inc. is a biotechnology company headquartered in South San Francisco, California, focused on developing genetic medicines and advancing the field of gene therapy.
Neuron23 is a biotechnology company founded in 2018 that focuses on developing precision therapeutics for genetic diseases. Headquartered in South San Francisco, California, the company relies on a team of scientific experts and entrepreneurs.
Addition Therapeutics is a biotechnology research company based in South San Francisco, California. The firm is on a mission to fulfill the promise of genomic medicine for chronic and rare diseases, having emerged from stealth with significant funding.
Frontier Medicines, Corp. is a precision medicine company focusing on drug development with offices in locations including South San Francisco, California, and Boston.
Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts.
Get BreezeBio's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on BreezeBio in Xcout Intel
- 2 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access